FDA Inspection
Wyeth Pharmaceutical Division of Wyeth Holdings LLCWyeth Pharmaceutical Division of Wyeth Holdings LLC – FDA Inspection, Apr 23, 2026
Record Details
This FDA Inspection record concerns Wyeth Pharmaceutical Division of Wyeth Holdings LLC, with an inspection on April 23, 2026, issued by the Atlanta District Office, covering biologics.
- Inspection Date
- April 23, 2026
- Product Type
- Biologics
View Company Profile
ID · 82c91522-3112-4d39-af5e-008f4aed37fa
Inspection Facts
- Inspection number
- 1305396
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.56(b)Written sanitation procedures lacking
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Wyeth Pharmaceutical Division of Wyeth Holdings LLC
10| Date | Classification | Office | Project area |
|---|---|---|---|
| October 17, 2024 | Not classified | Atlanta District Office | |
| November 10, 2023 | Not classified | Atlanta District Office | |
| November 18, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 26, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 19, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Wyeth Pharmaceutical Division of Wyeth Holdings LLC
- FDA Inspection 1252280 - 2024-10-17
- FDA Inspection 1234989 - 2023-11-10
- FDA Inspection 1192736 - 2022-11-18
- FDA Inspection 1121288 - 2019-11-26
- FDA Inspection 1051716 - 2018-04-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.